Eduardo Bruno Martins
2023
In 2023, Eduardo Bruno Martins earned a total compensation of $1.5M as Chief Medical Officer at Sagimet Biosciences, a 181% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $202,840 |
|---|---|
| Option Awards | $594,620 |
| Salary | $442,930 |
| Stock Awards | $265,127 |
| Other | $3,564 |
| Total | $1,509,081 |
Martins received $594.6K in option awards, accounting for 39% of the total pay in 2023.
Martins also received $202.8K in non-equity incentive plan, $442.9K in salary, $265.1K in stock awards and $3.6K in other compensation.
Rankings
In 2023, Eduardo Bruno Martins' compensation ranked 791st out of 3,006 executives tracked by ExecPay. In other words, Martins earned more than 73.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 791 out of 3,006 | 74th |
Division Manufacturing | 462 out of 1,650 | 72nd |
Major group Chemicals And Allied Products | 317 out of 918 | 66th |
Industry group Drugs | 309 out of 881 | 65th |
Industry Pharmaceutical Preparations | 206 out of 637 | 68th |
Source: SEC filing on April 18, 2024.
Martins' colleagues
We found three more compensation records of executives who worked with Eduardo Bruno Martins at Sagimet Biosciences in 2023.